drugset / Trial / NCT01049165
Single Ascending Dose (BMS-813160) Study
RandomizedParallel-groupTriple-blindBasic science
Summary
The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects
Timeline
- Start
- 2010-02
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-813160 | Small molecule | 5 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 20 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 60 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 150 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 300 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 600 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 1200 mg | Oral |
| Comparator | BMS-813160 | Small molecule | 2000 mg | Oral |
Indications
No indication recorded.